US 6162432
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
expired A61KA61K2039/505A61K38/00
Quick answer
US patent 6162432 (Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- THE REGENTS OF THE UNIVERSITY OF MICHIGAN
- Grant date
- Tue Dec 19 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 55
- CPC classes
- A61K, A61K2039/505, A61K38/00